The increased risk of AD in patients with DS is thought to be caused by the triplication and overexpression of the gene for the amyloid precursor protein (APP), located on chromosome 21, leading to altered production, aggregation, and deposition of amyloid beta-peptide (Aβ) in the brains of patients with DS [3, 4]. Here, APP is linked to Alzheimer disease.